Filter
153
Text search:
Booster
Featured
Recommendations
14
New Publications
32
Language
Document type
No document type
63
Guidelines
40
Studies & Reports
18
Fact sheets
13
Manuals
6
Strategic & Response Plan
5
Brochures
3
Situation Updates
2
Training Material
1
Resource Platforms
1
Videos
1
Countries / Regions
Global
9
India
5
Nigeria
3
Congo, Democratic Republic of
3
South Africa
3
Argentina
3
Namibia
3
Brazil
3
East and Southern Africa
3
Western and Central Europe
3
Africa
3
Ghana
2
Philippines
2
Germany
2
Zambia
2
Ukraine
2
Colombia
2
Lesotho
2
South–East Asia Region
2
Latin America and the Carribbean
2
Burkina Faso
1
Liberia
1
Senegal
1
Haiti
1
Nepal
1
Kenya
1
Rwanda
1
Indonesia
1
Mozambique
1
Benin
1
West and Central Africa
1
Venezuela
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Countries
47
Clinical Guidelines
32
Women & Child Health
10
Public Health
7
Key Resources
5
Pharmacy & Technologies
1
Toolboxes
COVID-19
38
NTDs
10
HIV
7
Mental Health
6
TB
6
Rapid Response
4
Caregiver
4
Pharmacy
4
Refugee
3
Ebola & Marburg
2
Polio
2
Natural Hazards
2
Planetary Health
2
NCDs
2
Conflict
1
AMR
1
Health Financing Toolbox
1
September 2021
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
Additional dose of the primary vaccination against COVID-19: Technical Guidelines
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br
...
Data received as of July 3, 2017 | WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2018
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at
...
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th
...
Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat
...
1 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
These guidelines have been extracted from the WHO manual Surgical Care at the District
Hospital (SCDH), which is a part of the WHO Integrated Management Package on Emergency
and Essential Surgical Care (IMPEESC).
Refer for details on anaesthesia, head, gunshot and landmine injuries in chapters
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
